• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Si-Bone

Si-Bone touts first human case with pelvic fracture fixation device

October 10, 2024 By Sean Whooley

Si-Bone today announced the first patient procedures with its FDA breakthrough device, the iFuse Torq TNT implant system. Santa Clara, California-based Si-Bone designed TNT to address the anatomic and biomechanical challenges of pelvic fragility fractures. It particularly helps in patients with poor bone quality, offering a significant advancement over traditional cannulated screws. TNT received FDA […]

Filed Under: Implants, Orthopedic Implants, Orthopedics Tagged With: Si-Bone

Si-Bone wins FDA clearance, breakthrough nod for pelvic fixation implant

August 21, 2024 By Danielle Kirsh

Si-Bone this week announced it received FDA 510(k) clearance and FDA breakthrough device designation for its iFuse Torq TNT Implant System. The Santa Clara, California-based orthopedic company designed the TNT implant for pelvic fragility fracture fixation and sacroilliac joint fusion. TNT (through and through) is designed to meet the specific anatomical and bone mineral density […]

Filed Under: 510(k), Food & Drug Administration (FDA), Orthopedics, Regulatory/Compliance Tagged With: Si-Bone

Si-Bone launches iFuse Bedrock Granite Implant system

May 8, 2024 By Danielle Kirsh

Si-Bone this week announced it launched its new iFuse Bedrock Granite Implant System and completed the first surgical procedures using the device. Santa Clara, California-based Si-Bone designed the iFuse Bedrock Granite implant for sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion. The system’s launch follows its January FDA 510(k) clearance, […]

Filed Under: Orthopedics, Pediatrics Tagged With: Si-Bone

Si-Bone grows sales 45% in Q1, raises full-year guidance

May 2, 2023 By Danielle Kirsh

Si-Bone this week posted first-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based orthopedic company reported profit losses of $11.1 million, or 32¢ per share, on sales of $32.7 million for the three months ended March 31, for a bottom-line gain of 36.1% on sales growth of 45.76% compared with […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: Si-Bone

Si-Bone expects 26% sales growth in Q4 results

January 11, 2023 By Danielle Kirsh

Si-Bone (Nasdaq:SIBN) this week announced preliminary fourth-quarter results that exceeded expectations on Wall Street. The Santa Clara, California-based orthopedic device company expects worldwide revenue to be in the range of $31.7-$31.9 million for Q4 2022. The sales represent a 26% growth year-over-year. For the full year 2022, Si-Bone anticipates reporting worldwide revenue in the range […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well, Orthopedics, Wall Street Beat Tagged With: Si-Bone

Si-Bone wins expanded FDA clearance for iFuse Bedrock Granite implant

December 27, 2022 By Sean Whooley

Si-Bone (Nasdaq:SIBN) announced today that it received additional FDA clearance for its iFuse Bedrock Granite implant. New indications for the implant include its use with a range of commercially available pedicle screw systems. Santa Clara, California-based Si-Bone received FDA 510(k) clearance for iFuse Bedrock Granite for spinal procedures in May. It designed the implant to […]

Filed Under: Business/Financial News, Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Regulatory/Compliance, Spine Tagged With: FDA, Si-Bone

Si-Bone wins FDA clearance for expanded iFuse-TORQ implant indication

June 13, 2022 By Sean Whooley

Si-Bone announced today that the FDA granted clearance for its iFuse-TORQ implant for pelvic fracture fixation. The regulatory nod expands Si-Bone’s iFuse-TORQ’s indication for acute, non-acute and non-traumatic pelvic fractures, including pelvic fragility fractures (fractures related to low-energy traumatic events) and pelvic insufficiency fractures. Santa Clara, California-based Si-Bone said in a news release that the […]

Filed Under: 510(k), Food & Drug Administration (FDA), Implants, Orthopedics, Regulatory/Compliance Tagged With: Si-Bone

Si-Bone wins FDA clearance for pelvic fixation, fusion tech

May 31, 2022 By Sean Whooley

Si-Bone announced today that it received FDA 510(k) clearance for its iFuse Bedrock Granite implant system for spinal procedures. Santa Clara, California-based Si-Bone designed the iFuse “Granite” implant to provide sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. According to a news release, FDA clearance follows earlier breakthrough device designation […]

Filed Under: 510(k), Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Regulatory/Compliance, Spine Tagged With: FDA, Si-Bone

Si-Bone posts mixed bag Q4 results

March 1, 2022 By Danielle Kirsh

Si-Bone (NSDQ:SIBN) this week posted fourth-quarter results that beat revenue consensus on Wall Street but miss earnings estimates. The Santa Clara, California-based musculoskeletal treatment device company reported losses of -$14.5 million, or -43¢ per share, on sales of $25.2 million for the three months ended Dec. 31, 2021 for a sales growth of 13.94% compared […]

Filed Under: MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: Si-Bone

Laura Francis to move up to CEO spot at Si-Bone

January 7, 2021 By Chris Newmarker

Si-Bone (NSDQ:SIBN) will promote its present CFO and COO Laura Francis into the corner office of the company, which makes the iFuse implant for treating lower back pain. Francis will become CEO once the company finds a new CFO or May 1 — whatever comes first. Present CEO Jeff Dunn will stay with the company as […]

Filed Under: Business/Financial News, Featured, Orthopedics, Spine Tagged With: Personnel Moves, Si-Bone

Si-Bone tops estimates with Q4 prelims | Wall Street Beat

January 7, 2019 By Sarah Faulkner

Si-Bone (NSDQ:SIBN) said today that it expects to record fourth-quarter sales of $15.4 million to $15.6 million, up 12 – 13% from the same period last year. The company pegged its full-year sales for 2018 between $55.2 million and $55.4 million, up 15% from 2017. Analysts on Wall Street are expecting Si-Bone to post Q4 sales […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Alphatec, Endologix, Luminex, Nevro Corp., Si-Bone

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy